Clinical Trial Details
— Status: Recruiting
Administrative data
NCT number |
NCT05150509 |
Other study ID # |
ORAL SQUAMOUS CELL CARCINOMA |
Secondary ID |
|
Status |
Recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
December 15, 2020 |
Est. completion date |
March 30, 2022 |
Study information
Verified date |
February 2022 |
Source |
Bangladesh Reference Institute of Chemical Measurements (BRICM) |
Contact |
Mala Khan, Dr. |
Phone |
+8801715032057 |
Email |
malakhan_07[@]yahoo.com |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
Oral Squamous Cell Carcinoma (OSCC) is the most common oral malignancy worldwide. The
prognosis of the OSCC patient is not significant despite the modern treatment facilities.
Late presentation is one of the most crucial cause of this and for that reason, the
importance of early diagnosis of OSCC should be the main concern. Till now, incisional biopsy
followed by histopathological examination is the gold standard for diagnosis of oral cancer.
The aim of the present study is to find out the association of salivary amino acid levels
with oral squamous cell carcinoma, whether the levels are increased or decreased in the
patient suffering from OSCC. This might be helpful for early diagnosis of oral cancer and
better prognosis.
Description:
1. Introduction:
Oral cancer is an abnormal growth of tissue, originates from the tissue in and around
the mouth which is uncoordinated with that of the surrounding normal tissue. Among all
oral cancers, oral squamous cell carcinoma (OSCC) is the most common (90%) malignant
epithelial neoplasm of the oral cavity. It is an alarming public health problem in the
world due to its prevalence, high incidence rate and mortality. According to the recent
data of GLOBOCAN 2020, 377713 newly diagnosed lip and oral cavity squamous cell
carcinoma patients diagnosed worldwide which is about 2% of all cancer reported. Oral
squamous cell carcinoma (OSCC) is the 6th most common cancer worldwide. Recent global
reports suggest that the largest portion of the reported cases are from Asia (65.8%),
but in the South Asia region, oral cancer is the 3rd most common cancer. One of the
critical factor of the high mortality rate of OSCC is that initially many of the lesion
is asymptomatic. As a result, they come at the late stage of the disease to the
physician and ultimately have a poor prognosis. Research showed that, when an OSCC is in
stage I, the 5-year survival rate is 80% but it drops to 20-40% when the disease is in
stage IV. For the diagnosis of OSCC, after the initial clinical examination, incisional
biopsy followed by histopathological examination is still considered as a gold standard,
but the method has many limitations. Invasive procedure needs special expertise for
taking biopsy sample from the representative areas and need expert histopathologist for
confirmation. Moreover, taking a tissue sample from behind the visible area such as the
base of the tongue, posterior pillar and incase of restricted jaw opening is very
difficult or sometimes impossible.
Human saliva is the secretion from three major salivary gland parotid, submandibular,
sublingual and numerous minor glands lie just beneath the mucosa of the oral cavity. It
consists of water (99.5%), inorganic salts and enzymes (0.2%) and proteins (0.3%). It is
helpful for the diagnosis of periodontitis, diabetes mellitus, HIV, dengue, mumps even
breast cancer, pancreatic cancer, gastric cancer, lung cancer and oral cancer.
Additionally, taking saliva samples has many advantages. Taking saliva is easier, and
needs no invasive procedure or expertise. Besides, it has a sufficient amount of
production and can be taken by the patient himself making the sample taking procedure
cheaper. Salivary amino acids are the important metabolites for the diagnosis of a
cancer patient. Amino acid is the raw product of protein synthesis. For this, when a
cancer patient passes through a hypermetabolic and hypercatabolic state, there is a
chance of protein imbalance. As the investigators know that amino acids are the
byproducts of protein, it can give us a hint for the state of imbalance due to any
cancer including oral squamous cell carcinoma. In addition, changes in amino acid
concentration in the body fluid of cancer patient is significant according to several
studies Mass spectrometry is a currently used platform for proteomics or metabolomics in
biomedical research. Like other spectrometry method such as gas chromatography-mass
spectrometry (GC-MS), capillary electrophoresis-mass spectrometry(CE-MS),
two-dimensional electrophoresis mass spectrometry (2DE-MS), matrix-assisted laser
desorption ionization-time of flight mass spectrometry (MALDI-TOF) and surface enhanced
laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF), Liquid
chromatography-mass spectrometry (LC-MS) is widely used nowadays. It allows a quick and
efficient separation and characterization of analytes in a given sample. Thus, it can
help in rapid diagnosis of any disease by automated analysis of amino acid profiles with
minimum effort and expenses. Many studies were conducted using LC-MS machine for saliva
analysis for the diagnosis of several diseases and found significant results. To the
best of my knowledge, very few studies were done to find out the salivary amino acid
level from the patient having suspected oral lesion by LC-MS. Moreover, no study was
performed for oral lesion diagnosis by analysis of amino acid profile using LC-MS in
Bangladesh. The aim of this study is to find out the association of specific salivary
amino acid levels with the patient of OSCC by Liquid Chromatography-Mass Spectrometry
(LC-MS).
2. Rationale:
OSCC is the 6th most common cancer worldwide, but in Asia the largest portion was
reported recently and in South-east Asia, it is the 3rd most common cancer. Poor
socio-economic condition, lack of consciousness and widely use of tobacco, betel quid
chewing and alcohol intake are the main factors behind this. Research showed that early
diagnosis of cancer reduces the mortality rate and hence can improve the treatment
outcome. As a result, scientists are trying to find out an easy, quick and reliable
method of diagnosis of OSCC.
Although scalpel (incisional) biopsy followed by histopathological examination is still
the gold standard for the diagnosis of the oral lesion but in the case of behind the
visible area and in restricted mouth opening it is very difficult to collect the
representative specimen. Moreover, the procedure is invasive and needs special equipment
and expertise. In this aspect, to avoid the risk of invasive procedures and pain, body
fluid analysis is the area of interest of the researcher nowadays.
Among the other body fluid, saliva is very easy to collect, non-invasive and might have
the property to diagnose of OSCC because it remains with the contact with the lesion. It
has plenty of flow and less costly than the others.
LC-MS machine is now widely used for metabolomics analysis all over the world. It has
the capacity to analyze a sample more effectively and within a very short time.
Measuring the amino acid and other components from the saliva can easily be done by this
method. Due to some diseases, amino acid concentration of body fluid differs according
to several studies. The investigators believe that for the Bangladeshi population there
are significant associations between several salivary amino acid levels and OSCC, which
can be identified by LC-MS.
3. General objective:
To find out the association of salivary amino acid levels with oral squamous cell
carcinoma (OSCC) identified by liquid chromatography-mass spectrometry.
4. Place of study:
Oral and Maxillofacial Surgery Department, Bangabandhu Sheikh Mujib Medical University
(BSMMU)and Bangladesh Reference Institute for Chemical Measurements (BRICM), Science
lab, Dhanmondi, Dhaka.
5. Study Population:
Patients and their attendants attending in outdoor and indoor clinic of Oral and
Maxillofacial Surgery Department, BSMMU according to inclusion and exclusion criteria.
Total sample size will be 110 and 55 in each group. Cases are the oral squamous cell
carcinoma patients confirmed by incisional biopsy and controls are the relatively same
age group and healthy individuals.
6. Study sample:
Patients attending to the Department of Oral & Maxillofacial Surgery,
histo-pathologically diagnosed as oral squamous cell carcinoma who will fulfill the
selection criteria will be selected as cases. Control subjects will be taken from
healthy individuals among the attendants of patients almost from the same age group of
cases maintaining the inclusion criteria. The participants are classified into two goups
Group A (Cases): Study group consists of 55 patients those having histopathologically
confirmed Oral Squamous Cell Carcinoma (OSCC) Group B (Controls): This group consists of
55 healthy individuals with nothaving any history of cancer and without severe
periodontal problems and dental caries.
7. Study variables:
- Histopathology report
- Level of salivary Amino acids detected by Liquid chromatography-mass spectrometry
(LC-MS)
8. Ethical consideration:
Ethical clearance for the study will be taken from the Institutional Review Board (IRB)
of BSMMU prior to the commencement of this study. After the research protocol is
approved by the committee, permission for the study will be taken from the Department of
Oral and Maxillofacial Surgery, Bangabandhu Sheikh Mujib Medical University.
The aims and objectives of the study along with its procedure, risks, stages and
benefits of this study will be explained to the study subjects in an easily
understandable local language. They will be assured that the risk of this research is
minimum. But, this risk will be properly addressed by specialist doctor. If any problem
arises related to the biopsy procedure or due to any step of this research activity,
they will get the whole treatment in free of cost. During and after research program
confidentiality would be maintained strictly. An ID number will be given to them and
that will be helpful to the research program. All the papers belong to this ID number
will be locked in office. Personal matter will not be used for analysis, producing
article and release. Only the involved investigator will know all these and nobody will
get their information.
Their participation in this research program is absolutely voluntary. They can either
deny participation or leave the research program at any time. That will not affect their
treatment process. Their legal right will not be harmed by signing the consent form. A
written informed consent will be taken from all the study subjects without exploiting
any of their weakness. All the study subjects will be assured about their
confidentiality and freedom to withdraw themselves from the study at any time.
9. Implementation of results:
The result might be helpful to find out the association betweensalivary amino
acidlevelsand oral squamous cell carcinoma (OSCC) patients. Thus, might be helpful in
early detection of OSCC.
The data will be helpful for future research and that will be considered baseline
information for public health department.
10. Aim and Procedure:
The aim of the study is to find out the association of salivary amino acid levels with oral
squamous cell carcinoma (OSCC).The study will be conducted at Oral and Maxillofacial Surgery
Department of Bangabandhu Sheikh Mujib Medical University Patient with histologically
confirmed OSCC will be enrolled as cases in the study by purposive convenient sampling
technique to achieve the desired number. Approximately same number of the healthy individuals
will be taken as control group for comparison. Then the saliva will be taken from the OSCC
patient and from the control group. After taking in the sterile container and ensuring proper
environment saliva sample will be carried to Designated Reference Institute for Chemical
Measurements (DRICM), Science lab, Dhanmondi for analysis by liquid chromatography-mass
spectrometry (LC-MS) machine. By this machine, the levels of 6 specific amino acids (Alanine,
Valine, Glycine, Phenylalanine, Isoleucine, Lysine) will be measured. The data obtained from
each individual will be recorded in predesigned data collection sheet separately. If
participents are agreeing to participate in this research program, the responsible doctor
will inform the participents in detail.